Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies for the treatment of Clostridium difficile-associated infection and disease

Antibodies for the treatment of Clostridium difficile-associated infection and disease

US Patent 8986697 · Granted Mar 24, 2015

Estimated economic value: $5,366,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-MSR1 antibodies and methods of use thereof2025
Multimeric hybrid Fc proteins for replacement of IVIG2025
Anti-TMPRSS6 antibodies and uses thereof2025
Anti-ALK2 antibodies and uses thereof2025
Steroids and protein-conjugates thereof2025
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof2025
Therapeutic uses of anti-GITR antibodies2025
Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof2025
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments2025
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof2025
Human antibodies to ebola virus glycoprotein2024
Tubulysins and protein-tubulysin conjugates2024